[HTML][HTML] A multiplexed, next generation sequencing platform for high-throughput detection of SARS-CoV-2
Population scale sweeps of viral pathogens, such as SARS-CoV-2, require high intensity
testing for effective management. Here, we describe “Systematic Parallel Analysis of RNA …
testing for effective management. Here, we describe “Systematic Parallel Analysis of RNA …
[HTML][HTML] A Multiplexed, Next Generation Sequencing Platform for High-Throughput Detection of SARS-CoV-2
M Aynaud, JJ Hernandez, S Barutcu, U Braunschweig… - 2020 - europepmc.org
Population scale sweeps of viral pathogens, such as SARS-CoV-2, that incorporate large
numbers of asymptomatic or mild symptom patients present unique challenges for public …
numbers of asymptomatic or mild symptom patients present unique challenges for public …
A Multiplexed, Next Generation Sequencing Platform for High-Throughput Detection of SARS-CoV-2
MM Aynaud, JJ Hernandez, S Barutcu… - medRxiv, 2020 - medrxiv.org
Population scale sweeps of viral pathogens, such as SARS-CoV-2, that incorporate large
numbers of asymptomatic or mild symptom patients present unique challenges for public …
numbers of asymptomatic or mild symptom patients present unique challenges for public …
A multiplexed, next generation sequencing platform for high-throughput detection of SARS-CoV-2
MM Aynaud, JJ Hernandez, S Barutcu… - Nature …, 2021 - pubmed.ncbi.nlm.nih.gov
Population scale sweeps of viral pathogens, such as SARS-CoV-2, require high intensity
testing for effective management. Here, we describe" Systematic Parallel Analysis of RNA …
testing for effective management. Here, we describe" Systematic Parallel Analysis of RNA …
A multiplexed, next generation sequencing platform for high-throughput detection of SARS-CoV-2
MM Aynaud, JJ Hernandez, S Barutcu… - Nature …, 2021 - econpapers.repec.org
Population scale sweeps of viral pathogens, such as SARS-CoV-2, require high intensity
testing for effective management. Here, we describe “Systematic Parallel Analysis of RNA …
testing for effective management. Here, we describe “Systematic Parallel Analysis of RNA …
A multiplexed, next generation sequencing platform for high-throughput detection of SARS-CoV-2.
MM Aynaud, JJ Hernandez, S Barutcu… - Nature …, 2021 - search.ebscohost.com
Population scale sweeps of viral pathogens, such as SARS-CoV-2, require high intensity
testing for effective management. Here, we describe “Systematic Parallel Analysis of RNA …
testing for effective management. Here, we describe “Systematic Parallel Analysis of RNA …
A multiplexed, next generation sequencing platform for high-throughput detection of SARS-CoV-2
MM Aynaud, JJ Hernandez, S Barutcu… - Nature …, 2021 - ideas.repec.org
Population scale sweeps of viral pathogens, such as SARS-CoV-2, require high intensity
testing for effective management. Here, we describe “Systematic Parallel Analysis of RNA …
testing for effective management. Here, we describe “Systematic Parallel Analysis of RNA …
[HTML][HTML] A multiplexed, next generation sequencing platform for high-throughput detection of SARS-CoV-2
MM Aynaud, JJ Hernandez, S Barutcu… - Nature …, 2021 - ncbi.nlm.nih.gov
Population scale sweeps of viral pathogens, such as SARS-CoV-2, require high intensity
testing for effective management. Here, we describe “Systematic Parallel Analysis of RNA …
testing for effective management. Here, we describe “Systematic Parallel Analysis of RNA …
A multiplexed, next generation sequencing platform for high-throughput detection of SARS-CoV-2
MM Aynaud, JJ Hernandez, S Barutcu… - Nature …, 2021 - ui.adsabs.harvard.edu
Population scale sweeps of viral pathogens, such as SARS-CoV-2, require high intensity
testing for effective management. Here, we describe" Systematic Parallel Analysis of RNA …
testing for effective management. Here, we describe" Systematic Parallel Analysis of RNA …
A Multiplexed, Next Generation Sequencing Platform for High-Throughput Detection of SARS-CoV-2
MM Aynaud, JJ Hernandez, S Barutcu… - 2020 - pesquisa.bvsalud.org
Population scale sweeps of viral pathogens, such as SARS-CoV-2, that incorporate large
numbers of asymptomatic or mild symptom patients present unique challenges for public …
numbers of asymptomatic or mild symptom patients present unique challenges for public …